Skip to main content
. 2022 Jan 29;11(3):720. doi: 10.3390/jcm11030720

Table 3.

Current therapeutic options for SDCs. The most promising therapeutic options according to literature are shown in bold.

Therapy
Targeted Therapy
nintedanib
sorafenib
trastuzumab, docetaxel
leuprorelin, bicalutamide
abiraterone
enzalutamide
chemotherapy
cisplatin
cyclophophamide, doxorubicin, cisplatin (CAP)
Immunotherapy
pembrolizumab, vorinostat